Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This transcript is a natural antisense long non-coding RNA that overlaps the BRAF gene locus in reverse orientation. Its primary function is to regulate the expression of BRAF by mechanisms such as transcriptional interference, chromatin modification, and RNA masking, thereby affecting the level and processing of functional BRAF mRNA and, subsequently, protein. It has no known protein product and is not considered a canonical therapeutic target, though its activity can shape disease-relevant BRAF signaling; high expression is associated with cancer prognosis in certain contexts[1][2][3][4].\n\nIf you want to map this to typical target fields in a database, it is best categorized under natural antisense transcripts / non-coding RNAs with regulatory rather than druggable or enzymatic roles.
RNA-based mechanisms such as RNA masking, transcriptional interference, altering chromatin environment, and modulating splicing/stability of BRAF mRNA. May affect sensitivity or expression of protein-coding BRAF, which itself is a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript antisense to BRAF.